Cite
APA Citation
Nakhaipour, H. R., Vudumula, U., Khurana, V., Sébire, G., Mah, J. K., Pohl, D., Schecter, R., & Adlard, N. (2021). cost-effectiveness of fingolimod versus interferon-β1a for the treatment of pediatric-onset multiple sclerosis in Canada. Journal of medical economics, 23, 1525–1533. http://access.bl.uk/ark:/81055/vdc_100124341454.0x000020